Global and United States Circulating Tumor Cell Diagnostics Market Size, Status and Forecast 2020-2026

Home/Global and United States Circulating Tumor Cell Diagnostics Market Size, Status and Forecast 2020-2026

Global and United States Circulating Tumor Cell Diagnostics Market Size, Status and Forecast 2020-2026

Healthcare, Pharma & Healthcare

Publication ID:

QYR11201665

Publication Date:

November 23, 2020

Pages:

127

Publisher:

QYR

Region:

Global

$3,900.00

Need Custom Market Research Solution?

Want to commission a custom market research to suit your needs? We are here to help. Let us know.

Printer version

Send by email

PDF version

Tabs

Description

Global Circulating Tumor Cell Diagnostics Scope and Market Size
Circulating Tumor Cell Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Circulating Tumor Cell Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
CTC Enrichment
CTC Detection
CTC Analysis

Market segment by Application, split into
Tumorigenesis research
EMT biomarkers development
Cancer stem cell research
Others

Based on regional and country-level analysis, the Circulating Tumor Cell Diagnostics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Circulating Tumor Cell Diagnostics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Janssen Diagnostics
Advanced Cell Diagnostics
Aviva Biosciences
Biocept Inc
Biofluidica Inc.
CellTraffix Inc.
Clearbridge BioMedics Pte Ltd
Epic Sciences Inc.
Fluxion Biosciences Inc.
ScreenCell
Silicon Biosystems
Sysmex Corporation
Greiner Bio-One GmbH
AdnaGen AG
Apocell Inc
Biocep Ltd
Canopus Bioscience Ltd
Creatv Microtech Inc
Ikonisys Inc
IV Diagnostics Inc
Miltenyi Biotech GmbH
Nanostring Technologies Inc
Rarecells Diagnostics.
Vitatex Inc

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cell Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 CTC Enrichment
1.2.3 CTC Detection
1.2.4 CTC Analysis
1.3 Market by Application
1.3.1 Global Circulating Tumor Cell Diagnostics Market Share by Application: 2020 VS 2026
1.3.2 Tumorigenesis research
1.3.3 EMT biomarkers development
1.3.4 Cancer stem cell research
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Circulating Tumor Cell Diagnostics Market Perspective (2015-2026)
2.2 Global Circulating Tumor Cell Diagnostics Growth Trends by Regions
2.2.1 Circulating Tumor Cell Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Circulating Tumor Cell Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Circulating Tumor Cell Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cell Diagnostics Players by Market Size
3.1.1 Global Top Circulating Tumor Cell Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Circulating Tumor Cell Diagnostics Revenue Market Share by Players (2015-2020)
3.2 Global Circulating Tumor Cell Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Circulating Tumor Cell Diagnostics Revenue
3.4 Global Circulating Tumor Cell Diagnostics Market Concentration Ratio
3.4.1 Global Circulating Tumor Cell Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cell Diagnostics Revenue in 2019
3.5 Key Players Circulating Tumor Cell Diagnostics Area Served
3.6 Key Players Circulating Tumor Cell Diagnostics Product Solution and Service
3.7 Date of Enter into Circulating Tumor Cell Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Circulating Tumor Cell Diagnostics Breakdown Data by Type (2015-2026)
4.1 Global Circulating Tumor Cell Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Circulating Tumor Cell Diagnostics Forecasted Market Size by Type (2021-2026)

5 Circulating Tumor Cell Diagnostics Breakdown Data by Application (2015-2026)
5.1 Global Circulating Tumor Cell Diagnostics Historic Market Size by Application (2015-2020)
5.2 Global Circulating Tumor Cell Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Circulating Tumor Cell Diagnostics Market Size (2015-2026)
6.2 North America Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020)
6.3 North America Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020)
6.4 North America Circulating Tumor Cell Diagnostics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Circulating Tumor Cell Diagnostics Market Size (2015-2026)
7.2 Europe Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020)
7.3 Europe Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020)
7.4 Europe Circulating Tumor Cell Diagnostics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe

8 China
8.1 China Circulating Tumor Cell Diagnostics Market Size (2015-2026)
8.2 China Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020)
8.3 China Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020)
8.4 China Circulating Tumor Cell Diagnostics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific

9 Japan
9.1 Japan Circulating Tumor Cell Diagnostics Market Size (2015-2026)
9.2 Japan Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020)
9.3 Japan Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020)
9.4 Japan Circulating Tumor Cell Diagnostics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Southeast Asia
10.1 Southeast Asia Circulating Tumor Cell Diagnostics Market Size (2015-2026)
10.2 Southeast Asia Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020)
10.3 Southeast Asia Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020)
10.4 Southeast Asia Circulating Tumor Cell Diagnostics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa

11 Key Players Profiles
11.1 Janssen Diagnostics
11.1.1 Janssen Diagnostics Company Details
11.1.2 Janssen Diagnostics Business Overview
11.1.3 Janssen Diagnostics Circulating Tumor Cell Diagnostics Introduction
11.1.4 Janssen Diagnostics Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020))
11.1.5 Janssen Diagnostics Recent Development
11.2 Advanced Cell Diagnostics
11.2.1 Advanced Cell Diagnostics Company Details
11.2.2 Advanced Cell Diagnostics Business Overview
11.2.3 Advanced Cell Diagnostics Circulating Tumor Cell Diagnostics Introduction
11.2.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
11.2.5 Advanced Cell Diagnostics Recent Development
11.3 Aviva Biosciences
11.3.1 Aviva Biosciences Company Details
11.3.2 Aviva Biosciences Business Overview
11.3.3 Aviva Biosciences Circulating Tumor Cell Diagnostics Introduction
11.3.4 Aviva Biosciences Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
11.3.5 Aviva Biosciences Recent Development
11.4 Biocept Inc
11.4.1 Biocept Inc Company Details
11.4.2 Biocept Inc Business Overview
11.4.3 Biocept Inc Circulating Tumor Cell Diagnostics Introduction
11.4.4 Biocept Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
11.4.5 Biocept Inc Recent Development
11.5 Biofluidica Inc.
11.5.1 Biofluidica Inc. Company Details
11.5.2 Biofluidica Inc. Business Overview
11.5.3 Biofluidica Inc. Circulating Tumor Cell Diagnostics Introduction
11.5.4 Biofluidica Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
11.5.5 Biofluidica Inc. Recent Development
11.6 CellTraffix Inc.
11.6.1 CellTraffix Inc. Company Details
11.6.2 CellTraffix Inc. Business Overview
11.6.3 CellTraffix Inc. Circulating Tumor Cell Diagnostics Introduction
11.6.4 CellTraffix Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
11.6.5 CellTraffix Inc. Recent Development
11.7 Clearbridge BioMedics Pte Ltd
11.7.1 Clearbridge BioMedics Pte Ltd Company Details
11.7.2 Clearbridge BioMedics Pte Ltd Business Overview
11.7.3 Clearbridge BioMedics Pte Ltd Circulating Tumor Cell Diagnostics Introduction
11.7.4 Clearbridge BioMedics Pte Ltd Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
11.7.5 Clearbridge BioMedics Pte Ltd Recent Development
11.8 Epic Sciences Inc.
11.8.1 Epic Sciences Inc. Company Details
11.8.2 Epic Sciences Inc. Business Overview
11.8.3 Epic Sciences Inc. Circulating Tumor Cell Diagnostics Introduction
11.8.4 Epic Sciences Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
11.8.5 Epic Sciences Inc. Recent Development
11.9 Fluxion Biosciences Inc.
11.9.1 Fluxion Biosciences Inc. Company Details
11.9.2 Fluxion Biosciences Inc. Business Overview
11.9.3 Fluxion Biosciences Inc. Circulating Tumor Cell Diagnostics Introduction
11.9.4 Fluxion Biosciences Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
11.9.5 Fluxion Biosciences Inc. Recent Development
11.10 ScreenCell
11.10.1 ScreenCell Company Details
11.10.2 ScreenCell Business Overview
11.10.3 ScreenCell Circulating Tumor Cell Diagnostics Introduction
11.10.4 ScreenCell Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
11.10.5 ScreenCell Recent Development
11.11 Silicon Biosystems
10.11.1 Silicon Biosystems Company Details
10.11.2 Silicon Biosystems Business Overview
10.11.3 Silicon Biosystems Circulating Tumor Cell Diagnostics Introduction
10.11.4 Silicon Biosystems Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.11.5 Silicon Biosystems Recent Development
11.12 Sysmex Corporation
10.12.1 Sysmex Corporation Company Details
10.12.2 Sysmex Corporation Business Overview
10.12.3 Sysmex Corporation Circulating Tumor Cell Diagnostics Introduction
10.12.4 Sysmex Corporation Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.12.5 Sysmex Corporation Recent Development
11.13 Greiner Bio-One GmbH
10.13.1 Greiner Bio-One GmbH Company Details
10.13.2 Greiner Bio-One GmbH Business Overview
10.13.3 Greiner Bio-One GmbH Circulating Tumor Cell Diagnostics Introduction
10.13.4 Greiner Bio-One GmbH Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.13.5 Greiner Bio-One GmbH Recent Development
11.14 AdnaGen AG
10.14.1 AdnaGen AG Company Details
10.14.2 AdnaGen AG Business Overview
10.14.3 AdnaGen AG Circulating Tumor Cell Diagnostics Introduction
10.14.4 AdnaGen AG Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.14.5 AdnaGen AG Recent Development
11.15 Apocell Inc
10.15.1 Apocell Inc Company Details
10.15.2 Apocell Inc Business Overview
10.15.3 Apocell Inc Circulating Tumor Cell Diagnostics Introduction
10.15.4 Apocell Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.15.5 Apocell Inc Recent Development
11.16 Biocep Ltd
10.16.1 Biocep Ltd Company Details
10.16.2 Biocep Ltd Business Overview
10.16.3 Biocep Ltd Circulating Tumor Cell Diagnostics Introduction
10.16.4 Biocep Ltd Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.16.5 Biocep Ltd Recent Development
11.17 Canopus Bioscience Ltd
10.17.1 Canopus Bioscience Ltd Company Details
10.17.2 Canopus Bioscience Ltd Business Overview
10.17.3 Canopus Bioscience Ltd Circulating Tumor Cell Diagnostics Introduction
10.17.4 Canopus Bioscience Ltd Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.17.5 Canopus Bioscience Ltd Recent Development
11.18 Creatv Microtech Inc
10.18.1 Creatv Microtech Inc Company Details
10.18.2 Creatv Microtech Inc Business Overview
10.18.3 Creatv Microtech Inc Circulating Tumor Cell Diagnostics Introduction
10.18.4 Creatv Microtech Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.18.5 Creatv Microtech Inc Recent Development
11.19 Ikonisys Inc
10.19.1 Ikonisys Inc Company Details
10.19.2 Ikonisys Inc Business Overview
10.19.3 Ikonisys Inc Circulating Tumor Cell Diagnostics Introduction
10.19.4 Ikonisys Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.19.5 Ikonisys Inc Recent Development
11.20 IV Diagnostics Inc
10.20.1 IV Diagnostics Inc Company Details
10.20.2 IV Diagnostics Inc Business Overview
10.20.3 IV Diagnostics Inc Circulating Tumor Cell Diagnostics Introduction
10.20.4 IV Diagnostics Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.20.5 IV Diagnostics Inc Recent Development
11.21 Miltenyi Biotech GmbH
10.21.1 Miltenyi Biotech GmbH Company Details
10.21.2 Miltenyi Biotech GmbH Business Overview
10.21.3 Miltenyi Biotech GmbH Circulating Tumor Cell Diagnostics Introduction
10.21.4 Miltenyi Biotech GmbH Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.21.5 Miltenyi Biotech GmbH Recent Development
11.22 Nanostring Technologies Inc
10.22.1 Nanostring Technologies Inc Company Details
10.22.2 Nanostring Technologies Inc Business Overview
10.22.3 Nanostring Technologies Inc Circulating Tumor Cell Diagnostics Introduction
10.22.4 Nanostring Technologies Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.22.5 Nanostring Technologies Inc Recent Development
11.23 Rarecells Diagnostics.
10.23.1 Rarecells Diagnostics. Company Details
10.23.2 Rarecells Diagnostics. Business Overview
10.23.3 Rarecells Diagnostics. Circulating Tumor Cell Diagnostics Introduction
10.23.4 Rarecells Diagnostics. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.23.5 Rarecells Diagnostics. Recent Development
11.24 Vitatex Inc
10.24.1 Vitatex Inc Company Details
10.24.2 Vitatex Inc Business Overview
10.24.3 Vitatex Inc Circulating Tumor Cell Diagnostics Introduction
10.24.4 Vitatex Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.24.5 Vitatex Inc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Tables and Figures

List of Tables
Table 1. Global Circulating Tumor Cell Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of CTC Enrichment
Table 4. Key Players of CTC Detection
Table 5. Key Players of CTC Analysis
Table 6. Global Circulating Tumor Cell Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Circulating Tumor Cell Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Circulating Tumor Cell Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Circulating Tumor Cell Diagnostics Market Share by Regions (2015-2020)
Table 10. Global Circulating Tumor Cell Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Circulating Tumor Cell Diagnostics Market Share by Regions (2021-2026)
Table 12. Circulating Tumor Cell Diagnostics Market Market Trends
Table 13. Circulating Tumor Cell Diagnostics Market Drivers
Table 14. Circulating Tumor Cell Diagnostics Market Challenges
Table 15. Circulating Tumor Cell Diagnostics Market Restraints
Table 16. Global Circulating Tumor Cell Diagnostics Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Circulating Tumor Cell Diagnostics Market Share by Players (2015-2020)
Table 18. Global Top Circulating Tumor Cell Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cell Diagnostics as of 2019)
Table 19. Global Circulating Tumor Cell Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Circulating Tumor Cell Diagnostics Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Circulating Tumor Cell Diagnostics Market Size Share by Type (2015-2020)
Table 25. Global Circulating Tumor Cell Diagnostics Revenue Market Share by Type (2021-2026)
Table 26. Global Circulating Tumor Cell Diagnostics Market Size Share by Application (2015-2020)
Table 27. Global Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 28. Global Circulating Tumor Cell Diagnostics Market Size Share by Application (2021-2026)
Table 29. North America Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Circulating Tumor Cell Diagnostics Market Share by Type (2015-2020)
Table 31. North America Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Circulating Tumor Cell Diagnostics Market Share by Application (2015-2020)
Table 33. North America Circulating Tumor Cell Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Circulating Tumor Cell Diagnostics Market Share by Country (2015-2020)
Table 35. Europe Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Circulating Tumor Cell Diagnostics Market Share by Type (2015-2020)
Table 37. Europe Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Circulating Tumor Cell Diagnostics Market Share by Application (2015-2020)
Table 39. Europe Circulating Tumor Cell Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Circulating Tumor Cell Diagnostics Market Share by Country (2015-2020)
Table 41. China Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 42. China Circulating Tumor Cell Diagnostics Market Share by Type (2015-2020)
Table 43. China Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 44. China Circulating Tumor Cell Diagnostics Market Share by Application (2015-2020)
Table 45. China Circulating Tumor Cell Diagnostics Market Size by Region (US$ Million) (2015-2020)
Table 46. China Circulating Tumor Cell Diagnostics Market Share by Region (2015-2020)
Table 47. Japan Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan Circulating Tumor Cell Diagnostics Market Share by Type (2015-2020)
Table 49. Japan Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan Circulating Tumor Cell Diagnostics Market Share by Application (2015-2020)
Table 51. Japan Circulating Tumor Cell Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan Circulating Tumor Cell Diagnostics Market Share by Country (2015-2020)
Table 53. Southeast Asia Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia Circulating Tumor Cell Diagnostics Market Share by Type (2015-2020)
Table 55. Southeast Asia Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia Circulating Tumor Cell Diagnostics Market Share by Application (2015-2020)
Table 57. Southeast Asia Circulating Tumor Cell Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia Circulating Tumor Cell Diagnostics Market Share by Country (2015-2020)
Table 59. Janssen Diagnostics Company Details
Table 60. Janssen Diagnostics Business Overview
Table 61. Janssen Diagnostics Product
Table 62. Janssen Diagnostics Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (US$ Million)
Table 63. Janssen Diagnostics Recent Development
Table 64. Advanced Cell Diagnostics Company Details
Table 65. Advanced Cell Diagnostics Business Overview
Table 66. Advanced Cell Diagnostics Product
Table 67. Advanced Cell Diagnostics Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (US$ Million)
Table 68. Advanced Cell Diagnostics Recent Development
Table 69. Aviva Biosciences Company Details
Table 70. Aviva Biosciences Business Overview
Table 71. Aviva Biosciences Product
Table 72. Aviva Biosciences Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (US$ Million)
Table 73. Aviva Biosciences Recent Development
Table 74. Biocept Inc Company Details
Table 75. Biocept Inc Business Overview
Table 76. Biocept Inc Product
Table 77. Biocept Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (US$ Million)
Table 78. Biocept Inc Recent Development
Table 79. Biofluidica Inc. Company Details
Table 80. Biofluidica Inc. Business Overview
Table 81. Biofluidica Inc. Product
Table 82. Biofluidica Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (US$ Million)
Table 83. Biofluidica Inc. Recent Development
Table 84. CellTraffix Inc. Company Details
Table 85. CellTraffix Inc. Business Overview
Table 86. CellTraffix Inc. Product
Table 87. CellTraffix Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (US$ Million)
Table 88. CellTraffix Inc. Recent Development
Table 89. Clearbridge BioMedics Pte Ltd Company Details
Table 90. Clearbridge BioMedics Pte Ltd Business Overview
Table 91. Clearbridge BioMedics Pte Ltd Product
Table 92. Clearbridge BioMedics Pte Ltd Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (US$ Million)
Table 93. Clearbridge BioMedics Pte Ltd Recent Development
Table 94. Epic Sciences Inc. Business Overview
Table 95. Epic Sciences Inc. Product
Table 96. Epic Sciences Inc. Company Details
Table 97. Epic Sciences Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (US$ Million)
Table 98. Epic Sciences Inc. Recent Development
Table 99. Fluxion Biosciences Inc. Company Details
Table 100. Fluxion Biosciences Inc. Business Overview
Table 101. Fluxion Biosciences Inc. Product
Table 102. Fluxion Biosciences Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (US$ Million)
Table 103. Fluxion Biosciences Inc. Recent Development
Table 104. ScreenCell Company Details
Table 105. ScreenCell Business Overview
Table 106. ScreenCell Product
Table 107. ScreenCell Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (US$ Million)
Table 108. ScreenCell Recent Development
Table 109. Silicon Biosystems Company Details
Table 110. Silicon Biosystems Business Overview
Table 111. Silicon Biosystems Product
Table 112. Silicon Biosystems Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (US$ Million)
Table 113. Silicon Biosystems Recent Development
Table 114. Sysmex Corporation Company Details
Table 115. Sysmex Corporation Business Overview
Table 116. Sysmex Corporation Product
Table 117. Sysmex Corporation Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (US$ Million)
Table 118. Sysmex Corporation Recent Development
Table 119. Greiner Bio-One GmbH Company Details
Table 120. Greiner Bio-One GmbH Business Overview
Table 121. Greiner Bio-One GmbH Product
Table 122. Greiner Bio-One GmbH Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (US$ Million)
Table 123. Greiner Bio-One GmbH Recent Development
Table 124. AdnaGen AG Company Details
Table 125. AdnaGen AG Business Overview
Table 126. AdnaGen AG Product
Table 127. AdnaGen AG Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (US$ Million)
Table 128. AdnaGen AG Recent Development
Table 129. Apocell Inc Company Details
Table 130. Apocell Inc Business Overview
Table 131. Apocell Inc Product
Table 132. Apocell Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (US$ Million)
Table 133. Apocell Inc Recent Development
Table 134. Biocep Ltd Company Details
Table 135. Biocep Ltd Business Overview
Table 136. Biocep Ltd Product
Table 137. Biocep Ltd Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (US$ Million)
Table 138. Biocep Ltd Recent Development
Table 139. Canopus Bioscience Ltd Company Details
Table 140. Canopus Bioscience Ltd Business Overview
Table 141. Canopus Bioscience Ltd Product
Table 142. Canopus Bioscience Ltd Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (US$ Million)
Table 143. Canopus Bioscience Ltd Recent Development
Table 144. Creatv Microtech Inc Company Details
Table 145. Creatv Microtech Inc Business Overview
Table 146. Creatv Microtech Inc Product
Table 147. Creatv Microtech Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (US$ Million)
Table 148. Creatv Microtech Inc Recent Development
Table 149. Ikonisys Inc Company Details
Table 150. Ikonisys Inc Business Overview
Table 151. Ikonisys Inc Product
Table 152. Ikonisys Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (US$ Million)
Table 153. Ikonisys Inc Recent Development
Table 154. IV Diagnostics Inc Company Details
Table 155. IV Diagnostics Inc Business Overview
Table 156. IV Diagnostics Inc Product
Table 157. IV Diagnostics Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (US$ Million)
Table 158. IV Diagnostics Inc Recent Development
Table 159. Miltenyi Biotech GmbH Company Details
Table 160. Miltenyi Biotech GmbH Business Overview
Table 161. Miltenyi Biotech GmbH Product
Table 162. Miltenyi Biotech GmbH Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (US$ Million)
Table 163. Miltenyi Biotech GmbH Recent Development
Table 164. Nanostring Technologies Inc Company Details
Table 165. Nanostring Technologies Inc Business Overview
Table 166. Nanostring Technologies Inc Product
Table 167. Nanostring Technologies Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (US$ Million)
Table 168. Nanostring Technologies Inc Recent Development
Table 169. Rarecells Diagnostics. Company Details
Table 170. Rarecells Diagnostics. Business Overview
Table 171. Rarecells Diagnostics. Product
Table 172. Rarecells Diagnostics. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (US$ Million)
Table 173. Rarecells Diagnostics. Recent Development
Table 174. Vitatex Inc Company Details
Table 175. Vitatex Inc Business Overview
Table 176. Vitatex Inc Product
Table 177. Vitatex Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (US$ Million)
Table 178. Vitatex Inc Recent Development
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Circulating Tumor Cell Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. CTC Enrichment Features
Figure 3. CTC Detection Features
Figure 4. CTC Analysis Features
Figure 5. Global Circulating Tumor Cell Diagnostics Market Share by Application: 2020 VS 2026
Figure 6. Tumorigenesis research Case Studies
Figure 7. EMT biomarkers development Case Studies
Figure 8. Cancer stem cell research Case Studies
Figure 9. Others Case Studies
Figure 10. Circulating Tumor Cell Diagnostics Report Years Considered
Figure 11. Global Circulating Tumor Cell Diagnostics Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Circulating Tumor Cell Diagnostics Market Share by Regions: 2020 VS 2026
Figure 13. Global Circulating Tumor Cell Diagnostics Market Share by Regions (2021-2026)
Figure 14. Global Circulating Tumor Cell Diagnostics Market Share by Players in 2019
Figure 15. Global Top Circulating Tumor Cell Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cell Diagnostics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Circulating Tumor Cell Diagnostics Revenue in 2019
Figure 17. North America Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Janssen Diagnostics Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 45. Advanced Cell Diagnostics Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 46. Aviva Biosciences Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 47. Biocept Inc Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 48. Biofluidica Inc. Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 49. CellTraffix Inc. Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 50. Clearbridge BioMedics Pte Ltd Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 51. Epic Sciences Inc. Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 52. Fluxion Biosciences Inc. Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 53. ScreenCell Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 54. Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 55. Sysmex Corporation Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 56. Greiner Bio-One GmbH Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 57. AdnaGen AG Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 58. Apocell Inc Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 59. Biocep Ltd Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 60. Canopus Bioscience Ltd Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 61. Creatv Microtech Inc Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 62. Ikonisys Inc Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 63. IV Diagnostics Inc Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 64. Miltenyi Biotech GmbH Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 65. Nanostring Technologies Inc Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 66. Rarecells Diagnostics. Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 67. Vitatex Inc Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Companies Covered

Janssen Diagnostics
Advanced Cell Diagnostics
Aviva Biosciences
Biocept Inc
Biofluidica Inc.
CellTraffix Inc.
Clearbridge BioMedics Pte Ltd
Epic Sciences Inc.
Fluxion Biosciences Inc.
ScreenCell
Silicon Biosystems
Sysmex Corporation
Greiner Bio-One GmbH
AdnaGen AG
Apocell Inc
Biocep Ltd
Canopus Bioscience Ltd
Creatv Microtech Inc
Ikonisys Inc
IV Diagnostics Inc
Miltenyi Biotech GmbH
Nanostring Technologies Inc
Rarecells Diagnostics.
Vitatex Inc

Report License Types

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Report Enquiry

Do you need more information about this report before making a purchase decision or wish to customize this report to suite your requirements?

If yes, then please use the form given below and we will get in touch with you immediately.

Kindly use your official email address and contact number to ensure speedy response.

Name *

Email *

Company

Contact Number *

Report Title *

Your Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Drag or click the correct shape to the grey "drop area".